nodes	percent_of_prediction	percent_of_DWPC	metapath
Chenodeoxycholic acid—CYP27A1—osteoporosis	0.357	1	CbGaD
Chenodeoxycholic acid—CYP27A1—Ergocalciferol—osteoporosis	0.195	0.569	CbGbCtD
Chenodeoxycholic acid—Drostanolone—Estradiol—osteoporosis	0.172	1	CrCrCtD
Chenodeoxycholic acid—CYP27A1—Cholecalciferol—osteoporosis	0.126	0.367	CbGbCtD
Chenodeoxycholic acid—NR1H4—skull—osteoporosis	0.00653	0.577	CbGeAlD
Chenodeoxycholic acid—CYP27A1—vertebral column—osteoporosis	0.00479	0.423	CbGeAlD
Chenodeoxycholic acid—NR1H4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00419	0.133	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Estropipate—osteoporosis	0.00398	0.0116	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Calcitriol—osteoporosis	0.00398	0.0116	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Ergocalciferol—osteoporosis	0.00318	0.00927	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Raloxifene—osteoporosis	0.00266	0.00773	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00256	0.00747	CbGbCtD
Chenodeoxycholic acid—CYP27A1—Vitamin D Metabolism—PTH—osteoporosis	0.00252	0.0798	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cholecalciferol—osteoporosis	0.00205	0.00597	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Conjugated Estrogens—osteoporosis	0.00188	0.00548	CbGbCtD
Chenodeoxycholic acid—CYP3A4—Estradiol—osteoporosis	0.00165	0.00481	CbGbCtD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts via 27-hydroxycholesterol—CYP27A1—osteoporosis	0.00161	0.051	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Vitamin D Metabolism—VDR—osteoporosis	0.0014	0.0443	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Endogenous sterols—CYP27A1—osteoporosis	0.00115	0.0362	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol—CYP27A1—osteoporosis	0.00111	0.035	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Synthesis of bile acids and bile salts—CYP27A1—osteoporosis	0.00101	0.0319	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Endogenous sterols—CYP19A1—osteoporosis	0.000824	0.026	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.000801	0.0253	CbGpPWpGaD
Chenodeoxycholic acid—Drostanolone—SHBG—osteoporosis	0.000774	0.577	CrCbGaD
Chenodeoxycholic acid—NR1H4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.00067	0.0212	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Endogenous sterols—CYP19A1—osteoporosis	0.000602	0.019	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.0006	0.019	CbGpPWpGaD
Chenodeoxycholic acid—Drostanolone—CYP19A1—osteoporosis	0.000568	0.423	CrCbGaD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000532	0.0168	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000501	0.0158	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Endogenous sterols—POMC—osteoporosis	0.000495	0.0156	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—VDR—osteoporosis	0.000477	0.0151	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000431	0.0136	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Orphan transporters—ANXA2—osteoporosis	0.000392	0.0124	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000385	0.0122	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000382	0.0121	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000377	0.0119	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—GPD2—osteoporosis	0.000365	0.0115	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Endogenous sterols—POMC—osteoporosis	0.000362	0.0114	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.000351	0.0111	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.00031	0.0098	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Fatty acid, triacylglycerol, and ketone body metabolism—OXCT1—osteoporosis	0.000284	0.00896	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000279	0.00883	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000278	0.00879	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.00023	0.00727	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP27A1—osteoporosis	0.000229	0.00724	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000227	0.00716	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000213	0.00672	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.00021	0.00663	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000199	0.00628	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—osteoporosis	0.000189	0.00598	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000186	0.00589	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—RXR and RAR heterodimerization with other nuclear receptor—TNF—osteoporosis	0.000177	0.00558	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000168	0.00531	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—CYP19A1—osteoporosis	0.000165	0.00521	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metapathway biotransformation—CYP19A1—osteoporosis	0.000162	0.00513	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000155	0.00488	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000153	0.00484	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000151	0.00476	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000145	0.00459	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP27A1—osteoporosis	0.000143	0.00451	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP27A1—osteoporosis	0.000141	0.00445	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000136	0.0043	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—CYP19A1—osteoporosis	0.00012	0.0038	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000113	0.00357	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00011	0.00348	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000102	0.00324	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Biological oxidations—POMC—osteoporosis	9.9e-05	0.00313	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	9.59e-05	0.00303	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ANXA2—osteoporosis	9.57e-05	0.00303	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—FDPS—osteoporosis	9.33e-05	0.00295	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PKM—osteoporosis	9.33e-05	0.00295	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PGLS—osteoporosis	8.85e-05	0.0028	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GPD2—osteoporosis	8.85e-05	0.0028	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.8e-05	0.00278	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PNP—osteoporosis	8.09e-05	0.00256	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ATIC—osteoporosis	8.09e-05	0.00256	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	7.62e-05	0.00241	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—U2AF1—osteoporosis	7.61e-05	0.0024	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	7.52e-05	0.00238	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—CYP19A1—osteoporosis	7.5e-05	0.00237	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.48e-05	0.00236	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metapathway biotransformation—CYP19A1—osteoporosis	7.4e-05	0.00234	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Biological oxidations—POMC—osteoporosis	7.23e-05	0.00229	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	7.18e-05	0.00227	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—AGER—osteoporosis	7.01e-05	0.00222	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—CA2—osteoporosis	6.88e-05	0.00218	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—OXCT1—osteoporosis	6.88e-05	0.00218	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PKM—osteoporosis	6.82e-05	0.00216	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—FDPS—osteoporosis	6.82e-05	0.00216	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—MGLL—osteoporosis	6.71e-05	0.00212	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PGLS—osteoporosis	6.47e-05	0.00204	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GPD2—osteoporosis	6.47e-05	0.00204	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.32e-05	0.002	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	6.17e-05	0.00195	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—ESR2—osteoporosis	6.05e-05	0.00191	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ATIC—osteoporosis	5.91e-05	0.00187	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PNP—osteoporosis	5.91e-05	0.00187	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—IDH2—osteoporosis	5.7e-05	0.0018	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—RPL24—osteoporosis	5.65e-05	0.00179	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	5.51e-05	0.00174	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ACP5—osteoporosis	5.22e-05	0.00165	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.15e-05	0.00163	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CA2—osteoporosis	5.03e-05	0.00159	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—OXCT1—osteoporosis	5.03e-05	0.00159	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	4.95e-05	0.00156	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—MGLL—osteoporosis	4.9e-05	0.00155	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—TPI1—osteoporosis	4.85e-05	0.00153	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—VDR—osteoporosis	4.81e-05	0.00152	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.62e-05	0.00146	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Estropipate—osteoporosis	4.57e-05	0.000546	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Zoledronate—osteoporosis	4.57e-05	0.000546	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Alendronate—osteoporosis	4.56e-05	0.000545	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Ibandronate—osteoporosis	4.56e-05	0.000545	CcSEcCtD
Chenodeoxycholic acid—Cough—Conjugated Estrogens—osteoporosis	4.56e-05	0.000545	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—P4HB—osteoporosis	4.56e-05	0.00144	CbGpPWpGaD
Chenodeoxycholic acid—Dyspnoea—Risedronate—osteoporosis	4.55e-05	0.000544	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Pamidronate—osteoporosis	4.53e-05	0.000542	CcSEcCtD
Chenodeoxycholic acid—Convulsion—Conjugated Estrogens—osteoporosis	4.53e-05	0.000541	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Zoledronate—osteoporosis	4.52e-05	0.00054	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	4.52e-05	0.00054	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Ethinyl Estradiol—osteoporosis	4.51e-05	0.000539	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Biological oxidations—POMC—osteoporosis	4.51e-05	0.00142	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Alendronate—osteoporosis	4.5e-05	0.000538	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Risedronate—osteoporosis	4.49e-05	0.000537	CcSEcCtD
Chenodeoxycholic acid—Eye disorder—Estradiol—osteoporosis	4.49e-05	0.000537	CcSEcCtD
Chenodeoxycholic acid—Tinnitus—Estradiol—osteoporosis	4.48e-05	0.000536	CcSEcCtD
Chenodeoxycholic acid—Constipation—Ethinyl Estradiol—osteoporosis	4.48e-05	0.000535	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—GAPDH—osteoporosis	4.47e-05	0.00141	CbGpPWpGaD
Chenodeoxycholic acid—Confusional state—Zoledronate—osteoporosis	4.47e-05	0.000534	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Calcitriol—osteoporosis	4.47e-05	0.000534	CcSEcCtD
Chenodeoxycholic acid—Cardiac disorder—Estradiol—osteoporosis	4.46e-05	0.000533	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Conjugated Estrogens—osteoporosis	4.45e-05	0.000532	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Conjugated Estrogens—osteoporosis	4.45e-05	0.000532	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Conjugated Estrogens—osteoporosis	4.45e-05	0.000532	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Ibandronate—osteoporosis	4.44e-05	0.000531	CcSEcCtD
Chenodeoxycholic acid—Nausea—Etidronic acid—osteoporosis	4.43e-05	0.00053	CcSEcCtD
Chenodeoxycholic acid—Oedema—Zoledronate—osteoporosis	4.43e-05	0.00053	CcSEcCtD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	4.42e-05	0.000528	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Pamidronate—osteoporosis	4.42e-05	0.000528	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Estropipate—osteoporosis	4.42e-05	0.000528	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Risedronate—osteoporosis	4.41e-05	0.000527	CcSEcCtD
Chenodeoxycholic acid—Infection—Zoledronate—osteoporosis	4.4e-05	0.000526	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Risedronate—osteoporosis	4.4e-05	0.000526	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Pamidronate—osteoporosis	4.39e-05	0.000524	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Ibandronate—osteoporosis	4.38e-05	0.000524	CcSEcCtD
Chenodeoxycholic acid—Constipation—Risedronate—osteoporosis	4.36e-05	0.000522	CcSEcCtD
Chenodeoxycholic acid—Pain—Risedronate—osteoporosis	4.36e-05	0.000522	CcSEcCtD
Chenodeoxycholic acid—Angiopathy—Estradiol—osteoporosis	4.36e-05	0.000521	CcSEcCtD
Chenodeoxycholic acid—Shock—Zoledronate—osteoporosis	4.36e-05	0.000521	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—RAP1A—osteoporosis	4.36e-05	0.00138	CbGpPWpGaD
Chenodeoxycholic acid—Paraesthesia—Pamidronate—osteoporosis	4.36e-05	0.000521	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Alendronate—osteoporosis	4.35e-05	0.00052	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Calcitriol—osteoporosis	4.35e-05	0.00052	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Zoledronate—osteoporosis	4.35e-05	0.000519	CcSEcCtD
Chenodeoxycholic acid—Immune system disorder—Estradiol—osteoporosis	4.34e-05	0.000519	CcSEcCtD
Chenodeoxycholic acid—Thrombocytopenia—Zoledronate—osteoporosis	4.34e-05	0.000519	CcSEcCtD
Chenodeoxycholic acid—Mediastinal disorder—Estradiol—osteoporosis	4.33e-05	0.000518	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Pamidronate—osteoporosis	4.33e-05	0.000517	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Zoledronate—osteoporosis	4.33e-05	0.000517	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Ethinyl Estradiol—osteoporosis	4.31e-05	0.000515	CcSEcCtD
Chenodeoxycholic acid—Chills—Estradiol—osteoporosis	4.31e-05	0.000515	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Pamidronate—osteoporosis	4.31e-05	0.000515	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Zoledronate—osteoporosis	4.3e-05	0.000514	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Calcitriol—osteoporosis	4.29e-05	0.000513	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Zoledronate—osteoporosis	4.28e-05	0.000512	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	4.28e-05	0.000512	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Raloxifene—osteoporosis	4.28e-05	0.000511	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Pamidronate—osteoporosis	4.27e-05	0.00051	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Estropipate—osteoporosis	4.27e-05	0.00051	CcSEcCtD
Chenodeoxycholic acid—Oedema—Conjugated Estrogens—osteoporosis	4.27e-05	0.00051	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—PKM—osteoporosis	4.25e-05	0.00134	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—FDPS—osteoporosis	4.25e-05	0.00134	CbGpPWpGaD
Chenodeoxycholic acid—Alopecia—Estradiol—osteoporosis	4.25e-05	0.000508	CcSEcCtD
Chenodeoxycholic acid—Infection—Conjugated Estrogens—osteoporosis	4.24e-05	0.000507	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Ibandronate—osteoporosis	4.24e-05	0.000506	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Zoledronate—osteoporosis	4.22e-05	0.000505	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Pamidronate—osteoporosis	4.22e-05	0.000504	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Alendronate—osteoporosis	4.21e-05	0.000503	CcSEcCtD
Chenodeoxycholic acid—Shock—Conjugated Estrogens—osteoporosis	4.2e-05	0.000502	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Pamidronate—osteoporosis	4.19e-05	0.000501	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Conjugated Estrogens—osteoporosis	4.18e-05	0.0005	CcSEcCtD
Chenodeoxycholic acid—Malnutrition—Estradiol—osteoporosis	4.18e-05	0.0005	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Pamidronate—osteoporosis	4.18e-05	0.0005	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Risedronate—osteoporosis	4.17e-05	0.000499	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—IDH2—osteoporosis	4.17e-05	0.00132	CbGpPWpGaD
Chenodeoxycholic acid—Tachycardia—Conjugated Estrogens—osteoporosis	4.16e-05	0.000498	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Ethinyl Estradiol—osteoporosis	4.16e-05	0.000497	CcSEcCtD
Chenodeoxycholic acid—Constipation—Pamidronate—osteoporosis	4.15e-05	0.000496	CcSEcCtD
Chenodeoxycholic acid—Pain—Pamidronate—osteoporosis	4.15e-05	0.000496	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Calcitriol—osteoporosis	4.15e-05	0.000496	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Conjugated Estrogens—osteoporosis	4.14e-05	0.000495	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Zoledronate—osteoporosis	4.14e-05	0.000495	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Ethinyl Estradiol—osteoporosis	4.14e-05	0.000494	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Ethinyl Estradiol—osteoporosis	4.14e-05	0.000494	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Raloxifene—osteoporosis	4.14e-05	0.000494	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Conjugated Estrogens—osteoporosis	4.13e-05	0.000493	CcSEcCtD
Chenodeoxycholic acid—Flatulence—Estradiol—osteoporosis	4.12e-05	0.000493	CcSEcCtD
Chenodeoxycholic acid—Tension—Estradiol—osteoporosis	4.11e-05	0.000491	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Estropipate—osteoporosis	4.11e-05	0.000491	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Ibandronate—osteoporosis	4.1e-05	0.000489	CcSEcCtD
Chenodeoxycholic acid—Rash—Estropipate—osteoporosis	4.07e-05	0.000487	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Estropipate—osteoporosis	4.07e-05	0.000486	CcSEcCtD
Chenodeoxycholic acid—Anorexia—Conjugated Estrogens—osteoporosis	4.07e-05	0.000486	CcSEcCtD
Chenodeoxycholic acid—Nervousness—Estradiol—osteoporosis	4.06e-05	0.000486	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Risedronate—osteoporosis	4.05e-05	0.000485	CcSEcCtD
Chenodeoxycholic acid—Back pain—Estradiol—osteoporosis	4.05e-05	0.000484	CcSEcCtD
Chenodeoxycholic acid—Headache—Estropipate—osteoporosis	4.05e-05	0.000483	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Alendronate—osteoporosis	4.04e-05	0.000483	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Zoledronate—osteoporosis	4.04e-05	0.000482	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Risedronate—osteoporosis	4.03e-05	0.000482	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Risedronate—osteoporosis	4.03e-05	0.000482	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—PGLS—osteoporosis	4.03e-05	0.00127	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GPD2—osteoporosis	4.03e-05	0.00127	CbGpPWpGaD
Chenodeoxycholic acid—Muscle spasms—Estradiol—osteoporosis	4.02e-05	0.000481	CcSEcCtD
Chenodeoxycholic acid—Rash—Alendronate—osteoporosis	4.01e-05	0.000479	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Zoledronate—osteoporosis	4.01e-05	0.000479	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Alendronate—osteoporosis	4.01e-05	0.000479	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	4e-05	0.00126	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Pamidronate—osteoporosis	4e-05	0.000478	CcSEcCtD
Chenodeoxycholic acid—Hypotension—Conjugated Estrogens—osteoporosis	3.99e-05	0.000476	CcSEcCtD
Chenodeoxycholic acid—Headache—Alendronate—osteoporosis	3.98e-05	0.000476	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Zoledronate—osteoporosis	3.98e-05	0.000476	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Raloxifene—osteoporosis	3.98e-05	0.000475	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Pamidronate—osteoporosis	3.97e-05	0.000474	CcSEcCtD
Chenodeoxycholic acid—Dyspnoea—Zoledronate—osteoporosis	3.95e-05	0.000472	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	3.95e-05	0.00125	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Raloxifene—osteoporosis	3.94e-05	0.000471	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Raloxifene—osteoporosis	3.94e-05	0.000471	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Zoledronate—osteoporosis	3.94e-05	0.000471	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Ibandronate—osteoporosis	3.94e-05	0.000471	CcSEcCtD
Chenodeoxycholic acid—Headache—Raloxifene—osteoporosis	3.92e-05	0.000468	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP27A1—osteoporosis	3.92e-05	0.00124	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Ibandronate—osteoporosis	3.9e-05	0.000467	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Ibandronate—osteoporosis	3.9e-05	0.000466	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Zoledronate—osteoporosis	3.9e-05	0.000466	CcSEcCtD
Chenodeoxycholic acid—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	3.89e-05	0.000465	CcSEcCtD
Chenodeoxycholic acid—Ill-defined disorder—Estradiol—osteoporosis	3.88e-05	0.000464	CcSEcCtD
Chenodeoxycholic acid—Headache—Ibandronate—osteoporosis	3.88e-05	0.000464	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Conjugated Estrogens—osteoporosis	3.86e-05	0.000461	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Ethinyl Estradiol—osteoporosis	3.86e-05	0.000461	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Calcitriol—osteoporosis	3.85e-05	0.000461	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Zoledronate—osteoporosis	3.85e-05	0.00046	CcSEcCtD
Chenodeoxycholic acid—Nausea—Estropipate—osteoporosis	3.84e-05	0.000458	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Pamidronate—osteoporosis	3.84e-05	0.000458	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Pamidronate—osteoporosis	3.84e-05	0.000458	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Conjugated Estrogens—osteoporosis	3.83e-05	0.000458	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal disorder—Zoledronate—osteoporosis	3.83e-05	0.000457	CcSEcCtD
Chenodeoxycholic acid—Angioedema—Estradiol—osteoporosis	3.82e-05	0.000457	CcSEcCtD
Chenodeoxycholic acid—Rash—Calcitriol—osteoporosis	3.82e-05	0.000457	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Zoledronate—osteoporosis	3.82e-05	0.000457	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Calcitriol—osteoporosis	3.82e-05	0.000456	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—ACP5—osteoporosis	3.81e-05	0.0012	CbGpPWpGaD
Chenodeoxycholic acid—Dyspnoea—Conjugated Estrogens—osteoporosis	3.8e-05	0.000455	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.8e-05	0.0012	CbGpPWpGaD
Chenodeoxycholic acid—Headache—Calcitriol—osteoporosis	3.8e-05	0.000454	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Conjugated Estrogens—osteoporosis	3.79e-05	0.000453	CcSEcCtD
Chenodeoxycholic acid—Pain—Zoledronate—osteoporosis	3.79e-05	0.000453	CcSEcCtD
Chenodeoxycholic acid—Constipation—Zoledronate—osteoporosis	3.79e-05	0.000453	CcSEcCtD
Chenodeoxycholic acid—Nausea—Alendronate—osteoporosis	3.78e-05	0.000451	CcSEcCtD
Chenodeoxycholic acid—Malaise—Estradiol—osteoporosis	3.77e-05	0.000451	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.76e-05	0.00119	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Risedronate—osteoporosis	3.76e-05	0.000449	CcSEcCtD
Chenodeoxycholic acid—Vertigo—Estradiol—osteoporosis	3.76e-05	0.000449	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Conjugated Estrogens—osteoporosis	3.76e-05	0.000449	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Ethinyl Estradiol—osteoporosis	3.76e-05	0.000449	CcSEcCtD
Chenodeoxycholic acid—Syncope—Estradiol—osteoporosis	3.75e-05	0.000448	CcSEcCtD
Chenodeoxycholic acid—Nausea—Raloxifene—osteoporosis	3.72e-05	0.000444	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Conjugated Estrogens—osteoporosis	3.71e-05	0.000443	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Ethinyl Estradiol—osteoporosis	3.7e-05	0.000443	CcSEcCtD
Chenodeoxycholic acid—Palpitations—Estradiol—osteoporosis	3.7e-05	0.000442	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—ATIC—osteoporosis	3.69e-05	0.00117	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PNP—osteoporosis	3.69e-05	0.00117	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	3.68e-05	0.00044	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Conjugated Estrogens—osteoporosis	3.68e-05	0.00044	CcSEcCtD
Chenodeoxycholic acid—Nausea—Ibandronate—osteoporosis	3.68e-05	0.00044	CcSEcCtD
Chenodeoxycholic acid—Loss of consciousness—Estradiol—osteoporosis	3.68e-05	0.00044	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—ESR1—osteoporosis	3.67e-05	0.00116	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Risedronate—osteoporosis	3.66e-05	0.000438	CcSEcCtD
Chenodeoxycholic acid—Feeling abnormal—Zoledronate—osteoporosis	3.65e-05	0.000436	CcSEcCtD
Chenodeoxycholic acid—Cough—Estradiol—osteoporosis	3.65e-05	0.000436	CcSEcCtD
Chenodeoxycholic acid—Pain—Conjugated Estrogens—osteoporosis	3.65e-05	0.000436	CcSEcCtD
Chenodeoxycholic acid—Constipation—Conjugated Estrogens—osteoporosis	3.65e-05	0.000436	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Zoledronate—osteoporosis	3.62e-05	0.000433	CcSEcCtD
Chenodeoxycholic acid—Hypertension—Estradiol—osteoporosis	3.61e-05	0.000432	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Risedronate—osteoporosis	3.61e-05	0.000431	CcSEcCtD
Chenodeoxycholic acid—Nausea—Calcitriol—osteoporosis	3.6e-05	0.00043	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.59e-05	0.00113	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Ethinyl Estradiol—osteoporosis	3.58e-05	0.000428	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Pamidronate—osteoporosis	3.57e-05	0.000427	CcSEcCtD
Chenodeoxycholic acid—Myalgia—Estradiol—osteoporosis	3.56e-05	0.000426	CcSEcCtD
Chenodeoxycholic acid—Chest pain—Estradiol—osteoporosis	3.56e-05	0.000426	CcSEcCtD
Chenodeoxycholic acid—Arthralgia—Estradiol—osteoporosis	3.56e-05	0.000426	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—TPI1—osteoporosis	3.54e-05	0.00112	CbGpPWpGaD
Chenodeoxycholic acid—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	3.54e-05	0.000423	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—ENO1—osteoporosis	3.52e-05	0.00111	CbGpPWpGaD
Chenodeoxycholic acid—Urticaria—Zoledronate—osteoporosis	3.52e-05	0.000421	CcSEcCtD
Chenodeoxycholic acid—Discomfort—Estradiol—osteoporosis	3.52e-05	0.000421	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Zoledronate—osteoporosis	3.5e-05	0.000419	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Zoledronate—osteoporosis	3.5e-05	0.000419	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Risedronate—osteoporosis	3.49e-05	0.000417	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	3.49e-05	0.000417	CcSEcCtD
Chenodeoxycholic acid—Dry mouth—Estradiol—osteoporosis	3.48e-05	0.000416	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Pamidronate—osteoporosis	3.48e-05	0.000416	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—PSMA5—osteoporosis	3.47e-05	0.0011	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—PSMA2—osteoporosis	3.47e-05	0.0011	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Ethinyl Estradiol—osteoporosis	3.46e-05	0.000414	CcSEcCtD
Chenodeoxycholic acid—Confusional state—Estradiol—osteoporosis	3.44e-05	0.000412	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Pamidronate—osteoporosis	3.43e-05	0.00041	CcSEcCtD
Chenodeoxycholic acid—Oedema—Estradiol—osteoporosis	3.42e-05	0.000408	CcSEcCtD
Chenodeoxycholic acid—Infection—Estradiol—osteoporosis	3.39e-05	0.000405	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Conjugated Estrogens—osteoporosis	3.39e-05	0.000405	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Risedronate—osteoporosis	3.37e-05	0.000403	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Conjugated Estrogens—osteoporosis	3.37e-05	0.000403	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Conjugated Estrogens—osteoporosis	3.37e-05	0.000403	CcSEcCtD
Chenodeoxycholic acid—Shock—Estradiol—osteoporosis	3.36e-05	0.000402	CcSEcCtD
Chenodeoxycholic acid—Nervous system disorder—Estradiol—osteoporosis	3.35e-05	0.0004	CcSEcCtD
Chenodeoxycholic acid—Tachycardia—Estradiol—osteoporosis	3.33e-05	0.000398	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—P4HB—osteoporosis	3.33e-05	0.00105	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Ethinyl Estradiol—osteoporosis	3.33e-05	0.000398	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Pamidronate—osteoporosis	3.32e-05	0.000397	CcSEcCtD
Chenodeoxycholic acid—Skin disorder—Estradiol—osteoporosis	3.32e-05	0.000396	CcSEcCtD
Chenodeoxycholic acid—Hyperhidrosis—Estradiol—osteoporosis	3.3e-05	0.000395	CcSEcCtD
Chenodeoxycholic acid—Rash—Ethinyl Estradiol—osteoporosis	3.3e-05	0.000394	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Ethinyl Estradiol—osteoporosis	3.3e-05	0.000394	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	3.28e-05	0.00104	CbGpPWpGaD
Chenodeoxycholic acid—Headache—Ethinyl Estradiol—osteoporosis	3.28e-05	0.000392	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—GAPDH—osteoporosis	3.27e-05	0.00103	CbGpPWpGaD
Chenodeoxycholic acid—Hypersensitivity—Zoledronate—osteoporosis	3.27e-05	0.00039	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—PSMA2—osteoporosis	3.26e-05	0.00103	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—PSMA5—osteoporosis	3.26e-05	0.00103	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Risedronate—osteoporosis	3.25e-05	0.000388	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.24e-05	0.00103	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	3.23e-05	0.00102	CbGpPWpGaD
Chenodeoxycholic acid—Rash—Risedronate—osteoporosis	3.22e-05	0.000385	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Risedronate—osteoporosis	3.22e-05	0.000384	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Pamidronate—osteoporosis	3.21e-05	0.000383	CcSEcCtD
Chenodeoxycholic acid—Headache—Risedronate—osteoporosis	3.2e-05	0.000382	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism—RAP1A—osteoporosis	3.18e-05	0.00101	CbGpPWpGaD
Chenodeoxycholic acid—Asthenia—Zoledronate—osteoporosis	3.18e-05	0.00038	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Conjugated Estrogens—osteoporosis	3.14e-05	0.000376	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Zoledronate—osteoporosis	3.14e-05	0.000375	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—OXCT1—osteoporosis	3.13e-05	0.000991	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CA2—osteoporosis	3.13e-05	0.000991	CbGpPWpGaD
Chenodeoxycholic acid—Musculoskeletal discomfort—Estradiol—osteoporosis	3.11e-05	0.000372	CcSEcCtD
Chenodeoxycholic acid—Nausea—Ethinyl Estradiol—osteoporosis	3.11e-05	0.000372	CcSEcCtD
Chenodeoxycholic acid—Insomnia—Estradiol—osteoporosis	3.09e-05	0.000369	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Pamidronate—osteoporosis	3.08e-05	0.000369	CcSEcCtD
Chenodeoxycholic acid—Paraesthesia—Estradiol—osteoporosis	3.07e-05	0.000366	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Conjugated Estrogens—osteoporosis	3.06e-05	0.000366	CcSEcCtD
Chenodeoxycholic acid—Rash—Pamidronate—osteoporosis	3.06e-05	0.000366	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Pamidronate—osteoporosis	3.06e-05	0.000365	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—MGLL—osteoporosis	3.05e-05	0.000966	CbGpPWpGaD
Chenodeoxycholic acid—Dyspnoea—Estradiol—osteoporosis	3.04e-05	0.000364	CcSEcCtD
Chenodeoxycholic acid—Headache—Pamidronate—osteoporosis	3.04e-05	0.000363	CcSEcCtD
Chenodeoxycholic acid—Somnolence—Estradiol—osteoporosis	3.04e-05	0.000363	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Zoledronate—osteoporosis	3.03e-05	0.000362	CcSEcCtD
Chenodeoxycholic acid—Nausea—Risedronate—osteoporosis	3.03e-05	0.000362	CcSEcCtD
Chenodeoxycholic acid—Pruritus—Conjugated Estrogens—osteoporosis	3.02e-05	0.000361	CcSEcCtD
Chenodeoxycholic acid—Dyspepsia—Estradiol—osteoporosis	3.01e-05	0.000359	CcSEcCtD
Chenodeoxycholic acid—Decreased appetite—Estradiol—osteoporosis	2.97e-05	0.000355	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—NRF2 pathway—TGFB1—osteoporosis	2.96e-05	0.000937	CbGpPWpGaD
Chenodeoxycholic acid—Gastrointestinal disorder—Estradiol—osteoporosis	2.95e-05	0.000352	CcSEcCtD
Chenodeoxycholic acid—Fatigue—Estradiol—osteoporosis	2.94e-05	0.000352	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Zoledronate—osteoporosis	2.93e-05	0.00035	CcSEcCtD
Chenodeoxycholic acid—Constipation—Estradiol—osteoporosis	2.92e-05	0.000349	CcSEcCtD
Chenodeoxycholic acid—Pain—Estradiol—osteoporosis	2.92e-05	0.000349	CcSEcCtD
Chenodeoxycholic acid—Diarrhoea—Conjugated Estrogens—osteoporosis	2.92e-05	0.000349	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—ESR2—osteoporosis	2.91e-05	0.000921	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Pamidronate—osteoporosis	2.88e-05	0.000344	CcSEcCtD
Chenodeoxycholic acid—Dizziness—Conjugated Estrogens—osteoporosis	2.82e-05	0.000337	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Zoledronate—osteoporosis	2.82e-05	0.000337	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—CYP19A1—osteoporosis	2.82e-05	0.00089	CbGpPWpGaD
Chenodeoxycholic acid—Feeling abnormal—Estradiol—osteoporosis	2.81e-05	0.000336	CcSEcCtD
Chenodeoxycholic acid—Rash—Zoledronate—osteoporosis	2.79e-05	0.000334	CcSEcCtD
Chenodeoxycholic acid—Gastrointestinal pain—Estradiol—osteoporosis	2.79e-05	0.000334	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Zoledronate—osteoporosis	2.79e-05	0.000334	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.78e-05	0.000878	CbGpPWpGaD
Chenodeoxycholic acid—Headache—Zoledronate—osteoporosis	2.78e-05	0.000332	CcSEcCtD
Chenodeoxycholic acid—Vomiting—Conjugated Estrogens—osteoporosis	2.71e-05	0.000324	CcSEcCtD
Chenodeoxycholic acid—Urticaria—Estradiol—osteoporosis	2.71e-05	0.000324	CcSEcCtD
Chenodeoxycholic acid—Body temperature increased—Estradiol—osteoporosis	2.7e-05	0.000323	CcSEcCtD
Chenodeoxycholic acid—Abdominal pain—Estradiol—osteoporosis	2.7e-05	0.000323	CcSEcCtD
Chenodeoxycholic acid—Rash—Conjugated Estrogens—osteoporosis	2.69e-05	0.000322	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Conjugated Estrogens—osteoporosis	2.69e-05	0.000321	CcSEcCtD
Chenodeoxycholic acid—Headache—Conjugated Estrogens—osteoporosis	2.67e-05	0.000319	CcSEcCtD
Chenodeoxycholic acid—Nausea—Zoledronate—osteoporosis	2.63e-05	0.000315	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—IDH2—osteoporosis	2.6e-05	0.000821	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ENO1—osteoporosis	2.57e-05	0.000814	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PSMA5—osteoporosis	2.54e-05	0.000802	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—PSMA2—osteoporosis	2.54e-05	0.000802	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Conjugated Estrogens—osteoporosis	2.53e-05	0.000303	CcSEcCtD
Chenodeoxycholic acid—Hypersensitivity—Estradiol—osteoporosis	2.52e-05	0.000301	CcSEcCtD
Chenodeoxycholic acid—Asthenia—Estradiol—osteoporosis	2.45e-05	0.000293	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP27A1—osteoporosis	2.44e-05	0.000772	CbGpPWpGaD
Chenodeoxycholic acid—Pruritus—Estradiol—osteoporosis	2.42e-05	0.000289	CcSEcCtD
Chenodeoxycholic acid—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.4e-05	0.00076	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ACP5—osteoporosis	2.38e-05	0.000751	CbGpPWpGaD
Chenodeoxycholic acid—Diarrhoea—Estradiol—osteoporosis	2.34e-05	0.000279	CcSEcCtD
Chenodeoxycholic acid—NR1H4—Gene Expression—VDR—osteoporosis	2.31e-05	0.000731	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—ADCY5—osteoporosis	2.3e-05	0.000727	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—GPX1—osteoporosis	2.29e-05	0.000725	CbGpPWpGaD
Chenodeoxycholic acid—Dizziness—Estradiol—osteoporosis	2.26e-05	0.00027	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—TPI1—osteoporosis	2.21e-05	0.000698	CbGpPWpGaD
Chenodeoxycholic acid—Vomiting—Estradiol—osteoporosis	2.17e-05	0.000259	CcSEcCtD
Chenodeoxycholic acid—Rash—Estradiol—osteoporosis	2.15e-05	0.000257	CcSEcCtD
Chenodeoxycholic acid—Dermatitis—Estradiol—osteoporosis	2.15e-05	0.000257	CcSEcCtD
Chenodeoxycholic acid—Headache—Estradiol—osteoporosis	2.14e-05	0.000256	CcSEcCtD
Chenodeoxycholic acid—CYP27A1—Metabolism—MTHFR—osteoporosis	2.12e-05	0.000669	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—P4HB—osteoporosis	2.08e-05	0.000656	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—CYP19A1—osteoporosis	2.06e-05	0.000651	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GAPDH—osteoporosis	2.04e-05	0.000644	CbGpPWpGaD
Chenodeoxycholic acid—Nausea—Estradiol—osteoporosis	2.03e-05	0.000242	CcSEcCtD
Chenodeoxycholic acid—UGT2B7—Metabolism—RAP1A—osteoporosis	1.99e-05	0.000627	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.95e-05	0.000616	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Generic Transcription Pathway—MYC—osteoporosis	1.91e-05	0.000604	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—ESR1—osteoporosis	1.77e-05	0.000559	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.72e-05	0.000545	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.7e-05	0.000537	CbGpPWpGaD
Chenodeoxycholic acid—CYP27A1—Metabolism—POMC—osteoporosis	1.69e-05	0.000535	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—ADCY5—osteoporosis	1.68e-05	0.000532	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—GPX1—osteoporosis	1.68e-05	0.00053	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ENO1—osteoporosis	1.6e-05	0.000507	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PSMA2—osteoporosis	1.58e-05	0.0005	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—PSMA5—osteoporosis	1.58e-05	0.0005	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—MTHFR—osteoporosis	1.55e-05	0.000489	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—CYP19A1—osteoporosis	1.28e-05	0.000405	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Metabolism—POMC—osteoporosis	1.24e-05	0.000391	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—ADCY5—osteoporosis	1.05e-05	0.000331	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—GPX1—osteoporosis	1.04e-05	0.00033	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Biological oxidations—POMC—osteoporosis	1.04e-05	0.000327	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PKM—osteoporosis	9.76e-06	0.000309	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—FDPS—osteoporosis	9.76e-06	0.000309	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—MTHFR—osteoporosis	9.64e-06	0.000305	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GPD2—osteoporosis	9.26e-06	0.000293	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PGLS—osteoporosis	9.26e-06	0.000293	CbGpPWpGaD
Chenodeoxycholic acid—NR1H4—Gene Expression—MYC—osteoporosis	9.2e-06	0.000291	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ATIC—osteoporosis	8.47e-06	0.000268	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PNP—osteoporosis	8.47e-06	0.000268	CbGpPWpGaD
Chenodeoxycholic acid—UGT2B7—Metabolism—POMC—osteoporosis	7.71e-06	0.000244	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—OXCT1—osteoporosis	7.2e-06	0.000228	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CA2—osteoporosis	7.2e-06	0.000228	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—MGLL—osteoporosis	7.02e-06	0.000222	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—IDH2—osteoporosis	5.97e-06	0.000189	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.61e-06	0.000177	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ACP5—osteoporosis	5.46e-06	0.000172	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—TPI1—osteoporosis	5.07e-06	0.00016	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—P4HB—osteoporosis	4.77e-06	0.000151	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GAPDH—osteoporosis	4.68e-06	0.000148	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—RAP1A—osteoporosis	4.56e-06	0.000144	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ENO1—osteoporosis	3.69e-06	0.000116	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PSMA2—osteoporosis	3.63e-06	0.000115	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—PSMA5—osteoporosis	3.63e-06	0.000115	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.95e-06	9.31e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—ADCY5—osteoporosis	2.41e-06	7.61e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—GPX1—osteoporosis	2.4e-06	7.58e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—MTHFR—osteoporosis	2.21e-06	7e-05	CbGpPWpGaD
Chenodeoxycholic acid—CYP3A4—Metabolism—POMC—osteoporosis	1.77e-06	5.6e-05	CbGpPWpGaD
